drugset
drugset / Trial / NCT05203432

Red Light Intervention on Myopic Progression

NCT05203432 ↗

Unknown 104 enrolled Shanghai Eye Disease Prevention and Treatment Center
RandomizedParallel-groupSingle-blindTreatment

Summary

To explore the effectiveness of using repeated low-level red-light therapy to slow myopia progression.

Timeline

Start
2022-02-10
Primary completion
2024-06-30
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 0.01 % —

Indications

myopia